Ceapro Inc V.CZO

5 major failures that could have been transformative

[Ciao]

Lots of excuses, no positive results, this is what a $500K/year CEO delivers

1) functional drink, that was a corporate target for 2020
2) Y-BG, in 2020 a phase 1/2 clinical protocol was planned to be submitted in Q4 2020
https://www.ceapro.com/news/press-releases/detail/199/ceapro-inc-provides-update-on-development-of-an-inhalable)[/url
this appears to be in limbo now
3) NCC, that was a corporate target fof 2020
4) BG pill, if the Italian study was read before the MHI study began, protocol calling for satchets could have been used
5) CoQ10 license, that was a corporate target for H2 2023 (with the CRO gone, so are the so called "serious" discussions?)

OATS, you have the ability to change these results, vote NO to the sham merger, then VOTE out Gilles at the AGM, and we can push for a new CEO

[Ciao]

Correction on the functional drink target: Functional drink: A functional drink with oat-BG impregnated with CoQ10 was highlighted in the Nov. 2018 corporate presentation with “Next Steps: Partnering and sales!” It was kept as a corporate milestone up to 2020 then taken out in 2021 without explanation.

[prophetoffactz]

It turned out oat beta glucan was viewed as too costly to process. Few people get it perfect on the first attempt. That's why speeches are re-written. That's why professional sports players practice so much. Heck, you couldn't even get your Stockhouse post right the first time and had to correct it.   Informed by the discussions with industry CZO has developed second

[prophetoffactz]

"4) BG pill, if the Italian study was read before the MHI study began, protocol calling for satchets could have been used" Only Ciao is dumb enough to think a liquid is superior to a pill. Who wants to cary around a liquid with them for when they take their medication? Convenience matters and CZO when with the ideal format. It was an experiment worth taking. How much of the sachet has